Figure 4.

Kaplan-Meier estimated relationship between GVHD and Hazard of Death in AML patients who received transplantation in Iran between 1991 and 2011. There was a significant relationship between survival and GVHD (p=0.002). Group 1: The patients who developed cGVHD only, Group 2: The patients who developed both aGVHD and cGVHD, Group 3: The patients who did not develop either aGVHD or cGVHD and Group 4: The patients who only developed aGVHD, 1-censored: Time of incidence of death in group 1, 2-censored: Time of incidence of death in group 2, 3-censored: Time of incidence of death in group 3, 4-censored: Time of incidence of death in group 4